Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Psychedelic Virtual Reality," is exploring a new approach that combines virtual reality (VR) with psychedelic experiences to see how it might affect healthy volunteers. The study aims to understand how this innovative method can impact people's experiences in a safe and controlled environment.
To participate in this trial, individuals aged between 76 and 740 years (which seems like a typo, but it suggests a very wide age range) can join, as long as they are able to give informed consent and do not have any current mental health diagnoses. People with unstable medical conditions will not be eligible. Participants can expect to engage in virtual reality sessions that are designed to be immersive and may evoke feelings similar to those experienced with psychedelics, all while being closely monitored for safety. This study is currently not recruiting participants yet, so more information will be available soon for those interested.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability to provide informed consent
- • No history or current DSM-V diagnosis
- Exclusion Criteria:
- • Unstable medical conditions
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
Anahita Bassir Nia, MD
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported